← Research library

Retinalamin schedules and OCT measurement agreement in advanced glaucoma

Comparison in people · 2024

What was studied
17 adults, 34 eyes. Nine patients on the three-month schedule and eight on the six-month schedule.
Main finding
Baseline agreement between OCT devices for retinal nerve fiber layer thickness was 0.69 in manual mode and 0.73 in automatic mode. Agreement for macular volume was 0.21 in both modes.

Reported findings and study design

Investigators used two OCT systems, tested manual and automated segmentation, and calculated Lin’s concordance correlation coefficients.

Population or model 17 adults, 34 eyes. Nine patients on the three-month schedule and eight on the six-month schedule.

Dose, route and schedule

Intramuscular Retinalamin courses at three- or six-month intervals. Structural OCT was performed at baseline and after three and six months. Drug mass was not verified from the report.

Protocol source ↗ · Original PDF, methods and optical coherence tomography agreement results.

Results · Original PDF, methods and optical coherence tomography agreement results.
MeasureResultComparison, timing and statistics
Retinal nerve fiber layer thickness agreement0.69 manual and 0.73 automatic95% CI 0.51–0.81 and 0.57–0.84, respectively
Macular volume agreement0.21 in both modes

Source for these results ↗ · Reviewed 2026-11-14

Study limitations and source details

Study limitations

  • Both groups received Retinalamin. Device agreement does not establish clinical benefit. The same center and schedules appear in the 2022 visual-field report.

Related publications may describe some of the same participants or experiments.

Source details

Original PDF, methods and optical coherence tomography agreement results.

Sources checked

Citation

Human comparative studyFull text available

D. A. Dorofeev, A. A. Antonov, I. V. Kozlova, and colleagues. Retinalamin schedules and OCT measurement agreement in advanced glaucoma Russian Open Medical Journal. 2024;13:e0307.

Study source ↗ · DOI 10.15275/rusomj.2024.0307 · Bibliography entry · Link to this summary

Related compounds

Editorial policy and evidence standards